Similar articles

• Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.

  Hickie RA. Hickie RA. Adv Exp Med Biol. 1977 May 22-24;92:451-88. doi: 10.1007/978-1-4615-8852-8_19. Adv Exp Med Biol. 1977. PMID: 24988 Review. No abstract available.
• Binding of cyclic nucleotides with soluble proteins increases in "differentiated" neuroblastoma cells in culture.

  Prasad KN, Sinha PK, Sahu SK, Brown JL. Prasad KN, et al. Biochem Biophys Res Commun. 1975 Sep 2;66(1):131-8. doi: 10.1016/s0006-291x(75)80304-4. Biochem Biophys Res Commun. 1975. PMID: 169841 No abstract available.
• Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.

  Hickie RA, Thompson WJ, Strada SJ, Couture-Murillo B, Morris HP, Robison GA. Hickie RA, et al. Cancer Res. 1977 Oct;37(10):3599-606. Cancer Res. 1977. PMID: 20224 No abstract available.
• The binding of cyclic nucleotides to membranes of the endoplasmic reticulum of normal and neoplastic rat liver.

  Sharma RK, McLaughlin CA, Pitot HC. Sharma RK, et al. Arch Biochem Biophys. 1976 Jul;175(1):221-8. doi: 10.1016/0003-9861(76)90502-6. Arch Biochem Biophys. 1976. PMID: 182077 No abstract available.
• [Cyclic nucleotides in clinical oncology].

  Bershteĭn LM. Bershteĭn LM. Vopr Onkol. 1982;28(8):86-100. Vopr Onkol. 1982. PMID: 6287734 Review. Russian. No abstract available.